Manufacturing CAR-T cell therapies

eBook published by Bioprocessing international mentioning Lonza as a proactive investor in development of closed platform systems for CAR-T.

You may also be interested in:

First Name Last Name Business Email Company Name Country

State

Join our community to receive tailored insights and resources. You can unsubscribe at any time.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

Building momemtum_QA_DEC24

Expert Q&A: Partnering for Success in the Supplement Market

Explore how Lonza's innovative platform and visionary approach to partnership empower brands with a...

AI-Enabled Route Scouting Service Scientists

Webinar (on-demand)

Innovative AI-Driven Solutions to Address the Growing Complexity of APIs

Developing innovative medicines often involves intricate small-molecule APIs with lengthy synthetic...

Webinar (on-demand)

Charting a Successful CMC Journey for Your ADC Drug Product

Bioconjugates and Antibody drug conjugates (ADCs) are revolutionizing cancer therapy with their...

ADC vial with gradient background - close crop

Expert Q&A: Accelerate Your ADC Journey

Filling the Need for Integrated Bioconjugate Solutions Antibody drug conjugates (ADCs) are...

KC Video thumbnail

mRNA and LNP Encapsulation Capabilities at our Geleen/NL Center of Excellence

Discover how our team, with its impressive mRNA/LNP track record, can help you progress your...

Mammalian Biologics Drug Substance Manufacture MC1

How Emerging Biotechs can Benefit by Partnering with a CDMO for Early Stage Development

The partnership between CDMOs and emerging biotech companies in early-stage development can be...

Bridging the Gaps in Oral Dosage Research: 4 Focus Areas Highlighted by the UNGAP network

As our designated center of excellence for novel drug delivery systems, Innovaform™ Accelerator is...

CAR-T Cells on the Fast Lane: From T-cell Selection to CAR-T Cell Drug Product in Just 3 Days

In this presentation, we explore the rapid growth of the CAR T market, driven by oncology...

Used as thumbnail for Powder to Particles podcast.

Unlocking the Potential of Carrier-Based Formulations: A Process Optimization Guide

Carrier-based formulations are commonly used in drug delivery systems, particularly in inhalation...

Webinar (on-demand)

Early Preclinical Development of mRNA/LNP Projects, Transitioning Successfully to cGMP...

View our on-demand webinar exploring the development steps that lead to an mRNA construct optimized...

Webinar (on-demand)

Enhanced GS® CHO Vector Technology for Improved Expression Control of Biotherapeutic Proteins

Many of today’s expression platforms for recombinant protein production have been optimised for the...

Used as thumbnail for Powder to Particles podcast.

Small Molecule API & HPAPI Development Capacity

This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma...